Brian Long

Company: 4DMT

Job title: Director, Biomarkers & Immunology

Seminars:

2:30PM Pharmacodynamic & Clinical Activity of 4D-310 in Fabry Patients with Low Capsid-Neutralizing Factors Detected Using a Cell Based Assay 2:30 pm

• Examining the pharmacodynamics of 4D-310 and its ability to overcome immune responses in Fabry patients with low capsid-neutralizing factors • Understanding the clinical activity of 4D-310 and its potential to improve patient outcomes in the context of Fabry disease • Discussing the role of cell-based assays in detecting capsid-neutralizing factors and optimizing gene therapy…Read more

day: Conference Day 1